Elaboration of regulatory approaches to managing the risk of the use of biomedical cell products in the Russian Federation
- Authors: Taube A.A.1,2, Alyautdin R.N.1, Merkulov V.A.1, Melnikova E.V.1, Goryachev D.V.1
-
Affiliations:
- Research Center for Examination of Medical Products Ministry of Health of the Russian Federation
- Saint Petersburg Chemopharmaceutical University
- Issue: Vol 70, No 5 (2021)
- Pages: 5-14
- Section: Articles
- URL: https://journals.eco-vector.com/0367-3014/article/view/113537
- DOI: https://doi.org/10.29296/25419218-2021-05-01
- ID: 113537
Cite item
Abstract
Full Text
About the authors
Aleksandra Al'bertovna Taube
Research Center for Examination of Medical Products Ministry of Health of the Russian Federation; Saint Petersburg Chemopharmaceutical University
Email: taubeaa@expmed.ru
Leading Researcher, Center for Planning and Coordination; Associate Professor of the Department of Economics and Management 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation; 14, Prof. Popov St., Saint Petersburg 197376, Russian Federation
Renad Nikolaevich Alyautdin
Research Center for Examination of Medical Products Ministry of Health of the Russian Federation
Email: alyautdin@expmed.ru
Director of the Department of Drug Safety Expertise; Doctor of Medical Sciences, Professor. 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Vadim Anatol'evich Merkulov
Research Center for Examination of Medical Products Ministry of Health of the Russian Federation
Email: merkulov@expmed.ru
Deputy General Director for Expertise, Doctor of Medical Sciences, Professor. 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Ekaterina Valer'evna Melnikova
Research Center for Examination of Medical Products Ministry of Health of the Russian Federation
Email: melnikovaev@expmed.ru
Head of the Laboratory of Biomedical Cell Products 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
Dmitriy Vladimirovich Goryachev
Research Center for Examination of Medical Products Ministry of Health of the Russian Federation
Email: gorachev@expmed.ru
Director of the Center for Expertise and Control of Medicinal Products, Doctor of Medical Sciences 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation
References
- Севастьянов В.И. Технологии тканевой инженерии и регенеративной медицины. Вестник трансплантологии и искусственных органов. 2014; 16 (3): 93-108. doi: 10.15825/1995-1191-2014-3-93-108
- Srinivasan N., Kellathur S.N., Lou H.-H. Cell and tissue therapy regulation: worldwide status and harmonization. Biologicals. 2012; 40 (3): 222-4. doi: 10.1016/j.biologicals.2012.01.004
- Vestergaard H.T., D'Apote L., Schneider C.K., Herberts C. The Evolution of Nonclinical Regulatory Science: Advanced Therapy Medicinal Products as a Paradigm. Molekular Therapia. 2013; 21 (9): 1644-8. doi: 10.1038/mt.2013.175
- Anastasaki E., Walker A., Bradshaw S. An Update on Clinical And Economic Evidence Requirements for Advanced Therapy Medicinal Products in Europe. 2014; 17 (7): A444. doi: 10.1016/j.jval.2014.08.1176
- Pearce K.F., Hildebrandt M., Greinix H. et al. Regulation of advanced therapy medicinal products in Europe and the role of academia. Cytotherapy. 2014; 16 (3): 289-97. doi: 10.1016/j.jcyt.2013.08.003
- Hanna E., Remuzat C., Auquier P., Toumi M. Advanced therapy medicinal products: current and future perspectives. J. Mark. Access. Health Policy. 2016; 4 (1): 31036. doi: 10.3402/jmahp.v4.31036
- Salmikangas P., Schuessler-Lenz M., Ruiz S. et al. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective. Adv. Exp. Med. Biol. 2015; 871: 103-30. doi: 10.1007/978-3-319-18618-4_6
- Madeira C., Santhagunam А., Salgueiro J., Cabra J.M.S. Advanced cell therapies for articular cartilage regeneration. Trends in Biotechnology. 2015; 33 (1): 35-42. doi: 10.1016/j.tibtech.2014.11.003
- Иволгин Д.А., Кудлай Д.А. Мезенхимальные мультипотентные стромальные клетки и онкобезопасность: две стороны одной медали или обоюдоострый меч (обзор зарубежной литературы). Российский журнал детской гематологии и онкологии. 2021; 8 (1): 64-84.
- Vigano M., Lugano G., Perucca Orfei C. et al. Autologous Microfragmented Adipose Tissue Reduces the Catabolic and Fibrosis Response in an in vitro model of Tendon Cell Inflammation. Stem. Cells Int. 2019; 5: 5620286. doi: 10.1155/2019/5620286
- Henriques D., Moreira R., Schwamborn J. et al. Successes and Hurdles in Stem Cells Application and Production for Brain Transplantation. Front Neurosci. 2019; 19 (13): 1194. doi: 10.3389/fnins.2019.01194